Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
DxTerity logo — Bringing the power of precision medicine to autoimmune disea...

DxTerity

Bringing the power of precision medicine to autoimmune disease

Founded 2006 United States Rancho Dominguez, United States 31 employees Venture round Total: $3.79M Biotechnology, Health Care

General Information

Company Name DxTerity
Founded Year 2006
Location United States Rancho Dominguez, United States
Employees 31
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with DxTerity. To contact DxTerity, visit dxterity.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DxTerity compare?

A PDF of DxTerity and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DxTerity soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DxTerity

DxTerity, with the slogan "Bringing the power of precision medicine to autoimmune disease," is a biotechnology and health care startup founded in 2006 and headquartered in the United States. The company is pioneering the use of RNA-based immune system profiling to gain a better understanding of the root causes of immune-mediated conditions. Their ultimate goal is to provide more personalized care for autoimmune sufferers while empowering patients with detailed information about their condition, helping them navigate their complex health journey more effectively. DxTerity recently received a $252.00K venture round investment on 13 October 2021. This startup is making significant strides in the field of precision medicine for autoimmune diseases, presenting a promising opportunity for investment in the health care and biotechnology industries.

Business keywords: Precision Medicine, Autoimmune Disease, RNA-based Immune System Profiling, Genomic Testing, Molecular Diagnostics, Oncology, Immune Response, Genomic Studies, Blood Diagnostics, Personalized Medicine, Lupus, Clinical Trials, High Frequency Genomics, Siteless Clinical Studies, Patient Recruitment

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $252.00K -
13 Oct 2021
Venture Round $100.00K -
12 Jan 2015
Debt Financing $2.60M -
17 Jan 2012
Series B $790.00K -
11 May 2010
Series A $56.25K -
14 Oct 2009

DxTerity Alternatives & Competitors

View All Alternatives
DxTerity vs
HTG Molecular Diagnostics
HTG Molecular Diagnostics United States

HTG is focused on advancing precision medicine

Post-IPO Equity
33 employees
Biotechnology, Health Care
Compare DxTerity vs HTG Molecular Diagnostics
DxTerity vs
Empire Genomics
Empire Genomics United States

The First Choice For Fluorescence In Situ Hybridization

Debt Financing
18 employees
Biotechnology, Health Care
DxTerity vs
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. United States

Every immune system has a story to tell; the key is knowing how to listen.

IPO
654 employees
Biotechnology, Health Care
Compare DxTerity vs Adaptive Biotechnologies Corp.
Also compare with: DxTerity vs Sano Genetics Sano Genetics View all alternatives

FAQ About DxTerity

Bringing the power of precision medicine to autoimmune disease
DxTerity was founded in 2006.
DxTerity is headquartered in Rancho Dominguez, United States.
DxTerity operates in Biotechnology and Health Care. Its work centres on Precision Medicine, Autoimmune Disease, RNA-based Immune System Profiling and Genomic Testing.
DxTerity has approximately 31 employees.
DxTerity has completed 5 funding rounds, raising a total of $3.79M. The latest funding stage is Venture round.
Top alternatives and competitors to DxTerity include HTG Molecular Diagnostics, Empire Genomics, Adaptive Biotechnologies Corp., Selah Genomics Inc, Predicine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DxTerity and HTG Molecular Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DxTerity, https://bouncewatch.com/company/dxterity, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes